Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-06-15

Clinical Trial Update: Coronary CT Angiography as the Primary Initial Method of Evaluating Patients With Subacute Chest Pain (CT PRIME)

View source ↗

Summary

The CT PRIME trial, assessing coronary CT angiography as the primary initial evaluation for subacute chest pain, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Corewell Health East | Conditions: Coronary Artery Disease | Status: WITHDRAWN